Publication | Closed Access

Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

UrologyPatient-derived XenograftsCancer PathologyTumor HeterogeneityMedicinePathologyProstatic DiseaseCancer GeneticsOncologyBrca2 Mutation CarriersTumor Biology